Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?
Nouara Yahi, Henri Chahinian, Jacques Fantini
Topics & Concepts
AntibodyVirologyEpitopeBiologyNeutralizationNeutralizing antibodyImmunologySARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies ResearchViral Infections and Immunology Research